Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease.
Kreijne JE, Goetgebuer RL, Erler NS, De Boer NK, Siebers AG, Dijkstra G, van Kemenade FA, Hoentjen F, Oldenburg B, van der Meulen AE, Ponsioen CIJ, Pierik MJ, van der Woude CJ, de Vries AC; Dutch Initiative on Crohn and Colitis (ICC).
Kreijne JE, et al. Among authors: van der woude cj, van kemenade fa, van der meulen ae.
Aliment Pharmacol Ther. 2023 Jul;58(2):207-217. doi: 10.1111/apt.17555. Epub 2023 May 23.
Aliment Pharmacol Ther. 2023.
PMID: 37221820